These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9427540)

  • 1. Production, characterization and functional activities of v-Ski in cultured cells.
    Kelder B; Richmond C; Stavnezer E; List EO; Kopchick JJ
    Gene; 1997 Nov; 202(1-2):15-21. PubMed ID: 9427540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site.
    Nicol R; Stavnezer E
    J Biol Chem; 1998 Feb; 273(6):3588-97. PubMed ID: 9452486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI.
    Tarapore P; Richmond C; Zheng G; Cohen SB; Kelder B; Kopchick J; Kruse U; Sippel AE; Colmenares C; Stavnezer E
    Nucleic Acids Res; 1997 Oct; 25(19):3895-903. PubMed ID: 9380514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP-4- and AP-5-like proteins from mouse L cells are trans-activators and bind to the GT-II region of SV40 early TRE in a mutually exclusive manner.
    Hou YT; Coleman TA; Kopchick JJ
    Gene; 1995 Sep; 162(2):197-203. PubMed ID: 7557429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a core functional and structural domain of the v-Ski oncoprotein responsible for both transformation and myogenesis.
    Zheng G; Teumer J; Colmenares C; Richmond C; Stavnezer E
    Oncogene; 1997 Jul; 15(4):459-71. PubMed ID: 9242383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of transcriptional activation and oncogenic transformation by v-Myb.
    Chen RH; Fields S; Lipsick JS
    Oncogene; 1995 Nov; 11(9):1771-9. PubMed ID: 7478605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ski interacts with the evolutionarily conserved SNW domain of Skip.
    Prathapam T; Kühne C; Hayman M; Banks L
    Nucleic Acids Res; 2001 Sep; 29(17):3469-76. PubMed ID: 11522815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-regulation of myogenin promoter/enhancer activity by c-ski during skeletal-muscle differentiation: the C-terminus of the c-Ski protein is essential for transcriptional regulatory activity in myotubes.
    Ichikawa K; Nagase T; Ishii S; Asano A; Mimura N
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):607-13. PubMed ID: 9371722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the DNA binding and transcriptional activation domains of the erg protein.
    Siddique HR; Rao VN; Lee L; Reddy ES
    Oncogene; 1993 Jul; 8(7):1751-5. PubMed ID: 8510921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
    Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K
    Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells.
    Chen SL; Wang SC; Hosking B; Muscat GE
    Mol Endocrinol; 2001 May; 15(5):783-96. PubMed ID: 11328858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling.
    Wu JW; Krawitz AR; Chai J; Li W; Zhang F; Luo K; Shi Y
    Cell; 2002 Nov; 111(3):357-67. PubMed ID: 12419246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
    Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
    Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baculovirus transregulator IE1 requires a dimeric nuclear localization element for nuclear import and promoter activation.
    Olson VA; Wetter JA; Friesen PD
    J Virol; 2002 Sep; 76(18):9505-15. PubMed ID: 12186932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation by human c-myb and v-myb genes.
    Kalkbrenner F; Guehmann S; Moelling K
    Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.